Author:
Pirani Hossein,Soltany Afsaneh,Hossein Rezaei Maryam,Khodabakhshi Fard Adeleh,Nikooei Rohollah,Khoramipoor Kimya,Chamari Karim,Khoramipour Kayvan
Abstract
AbstractImpaired autophagy is a hallmark of diabetes. The current study proposed to investigate if high intensity interval training (HIIT) induced lactate accumulation could stimulate autophagy in type 2 diabetic male rats. 28 male Wistar rats were randomly assigned into four groups: Healthy Control (CO), Diabetes Control (T2D), Exercise (EX), and Diabetes + Exercise (T2D + EX). Diabetes was induced by feeding high-fat diet and administrating single dose of streptozotocin (35 mg/kg). After becoming diabetic, the animals in the exercise groups (EX and T2D + EX) performed an eight-week HIIT (4–10 interval, 80–100% Vmax, 5 days per week). Serum levels of lactate, glucose and insulin as well as the levels of lactate, pyruvate, lactate transporter monocarboxylate transporter 1 (MCT1), phosphorylated mitogen-activated protein kinases (p-MAP 1 and 2), phosphorylated extracellular signal-regulated protein kinases 1 and 2 (p-ERK 1 and 2), mammalian target of rapamycin (p-mTOR), ribosomal protein S6 kinase beta-1 (p-70S6k), p90 ribosomal S6 kinases (p-90RSK), autophagy related 7 (ATG7), Beclin-1, microtubule-associated protein 1A/1B, and 2A/2B -light chain 3 levels (LC3-I), (LC3- II), (LC3I/LC3II) in soleus muscle were measured. Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) and serum glucose was lower in T2D + EX compared to T2D group (P < 0.0001). While serum and soleus muscle levels of lactate was not different between T2D and T2D + Ex, the levels of Pyruvate (P < 0.01), MCT1, p-ERK1/2, p-mTOR, p70S6k, P-90RSK, ATG7, LC3-II, and LC3-II/LC3I ratios were higher in T2D + EX compared to T2D group (P < 0.0001). We concluded that eight weeks of high-intensity interval training could activated ERK/P90SRK while inhibiting mTOR/P70S6K signaling pathway in lactate dependent manner. It means increased autophagy which resulted in improve insulin resistance (IR) and reduce blood glucose.
Publisher
Springer Science and Business Media LLC
Reference53 articles.
1. Arroyave, F., Montaño, D. & Lizcano, F. Diabetes mellitus is a chronic disease that can benefit from therapy with induced pluripotent stem cells. Int. J. Mol. Sci. 21(22), 8685 (2020).
2. Khoramipour, K., Hekmatikar, A. A. & Sotvan, H. An overview of Fatmax and MFO in exercise. Razi. J. Med. Sci. 27, 49–59 (2020).
3. Larejani, B. & Zahedi, F. Epidemiology of diabetes mellitus in Iran. Iran. J. Diab. Metab. 1(1), 1–8 (2001).
4. Lautsch, D. et al. Individualized HbA 1c goals, and patient awareness and attainment of goals in type 2 diabetes mellitus: A real-world multinational survey. Adv. Ther. 1, 1–17 (2022).
5. Gonzalez, C. D. et al. The emerging role of autophagy in the pathophysiology of diabetes mellitus. Autophagy 7(1), 2–11 (2011).